Adding pharmacogenetics information to drug labels: Lessons learned

Abstract:

The US Food and Drug Administration approved a revised package insert for two cancer drugs to include information about the increased risk of severe adverse events owing to enzyme deficiencies caused by genetic variants. The label revisions stopped...

Type:

Journal Article

Date:

2006

Authors and Contributors:

Susanne B. Haga Kenneth E. Thummel Wylie Burke

Pages:

847–854

Site link:

Read the Journal Article: Adding pharmacogenetics information to drug labels: Lessons learned

URL Citation:

https://journals.lww.com/jpharmacogenetics/Abstract/2006/12000/Adding_pharmacogenetics_information_to_drug.1.aspx

Issue:

12

Volume:

16

Publication:

Pharmacogenetics and Genomics

LawSeq^SM Record Last Modified:

08/07/2018